-
1
-
-
84878356025
-
Accelerating next-generation vaccine development for global disease prevention
-
Koff WC, et al. Accelerating next-generation vaccine development for global disease prevention. Science. 2013;340(6136):1232910.
-
(2013)
Science
, vol.340
, Issue.6136
, pp. 1232910
-
-
Koff, W.C.1
-
2
-
-
44049108744
-
Toward an AIDS vaccine
-
Walker BD, Burton DR. Toward an AIDS vaccine. Science. 2008;320(5877):760-764.
-
(2008)
Science
, vol.320
, Issue.5877
, pp. 760-764
-
-
Walker, B.D.1
Burton, D.R.2
-
3
-
-
84873506978
-
Designing tomorrow's vaccines
-
Nabel GJ. Designing tomorrow's vaccines. N Engl J Med. 2013;368(6):551-560.
-
(2013)
N Engl J Med
, vol.368
, Issue.6
, pp. 551-560
-
-
Nabel, G.J.1
-
4
-
-
85001019062
-
Vaccine adjuvants: From 1920 to 2015 and beyond
-
Di Pasquale A, Preiss S, Da Silva FT, Garcon N. Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines. 2015;3(2):320-343.
-
(2015)
Vaccines
, vol.3
, Issue.2
, pp. 320-343
-
-
Pasquale, A.D.I.1
Preiss, S.2
Da Silva, F.T.3
Garcon, N.4
-
5
-
-
84889770121
-
Key roles of adjuvants in modern vaccines
-
Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19(12):1597-1608.
-
(2013)
Nat Med
, vol.19
, Issue.12
, pp. 1597-1608
-
-
Reed, S.G.1
Orr, M.T.2
Fox, C.B.3
-
7
-
-
0035830278
-
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in the Gambia: A randomised trial
-
Bojang KA, et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet. 2001;358(9297):1927-1934.
-
(2001)
Lancet
, vol.358
, Issue.9297
, pp. 1927-1934
-
-
Bojang, K.A.1
-
8
-
-
84914695671
-
Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development
-
Lewis GK, DeVico AL, Gallo RC. Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development. Proc Natl Acad Sci U S A. 2014;111(44):15614-15621.
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, Issue.44
, pp. 15614-15621
-
-
Lewis, G.K.1
DeVico, A.L.2
Gallo, R.C.3
-
9
-
-
84863774072
-
Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses
-
Burton DR, Poignard P, Stanfield RL, Wilson IA. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science. 2012;337(6091):183-186.
-
(2012)
Science
, vol.337
, Issue.6091
, pp. 183-186
-
-
Burton, D.R.1
Poignard, P.2
Stanfield, R.L.3
Wilson, I.A.4
-
10
-
-
84861963478
-
The mechanism of action of MF59-an innately attractive adjuvant formulation
-
O'Hagan DT, Ott GS, De Gregorio E, Seubert A. The mechanism of action of MF59-an innately attractive adjuvant formulation. Vaccine. 2012;30(29):4341-4348.
-
(2012)
Vaccine
, vol.30
, Issue.29
, pp. 4341-4348
-
-
O'Hagan, D.T.1
Ott, G.S.2
De Gregorio, E.3
Seubert, A.4
-
11
-
-
0032827427
-
Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice
-
Dupuis M, McDonald DM, Ott G. Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice. Vaccine. 1999; 18(5-6):434-439.
-
(1999)
Vaccine
, vol.18
, Issue.5-6
, pp. 434-439
-
-
Dupuis, M.1
McDonald, D.M.2
Ott, G.3
-
12
-
-
77956405814
-
The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant
-
De Veer M, Kemp J, Chatelier J, Elhay MJ, Meeusen EN. The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant. Vaccine. 2010;28(40):6597-6602.
-
(2010)
Vaccine
, vol.28
, Issue.40
, pp. 6597-6602
-
-
De Veer, M.1
Kemp, J.2
Chatelier, J.3
Elhay, M.J.4
Meeusen, E.N.5
-
13
-
-
84922573075
-
Vaccine adjuvant MF59 promotes retention of unprocessed antigen in lymph node macrophage compartments and follicular dendritic cells
-
Cantisani R, et al. Vaccine adjuvant MF59 promotes retention of unprocessed antigen in lymph node macrophage compartments and follicular dendritic cells. J Immunol. 2015;194(4):1717-1725.
-
(2015)
J Immunol
, vol.194
, Issue.4
, pp. 1717-1725
-
-
Cantisani, R.1
-
14
-
-
0025287316
-
Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration
-
Supersaxo A, Hein WR, Steffen H. Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm Res. 1990;7(2):167-169.
-
(1990)
Pharm Res
, vol.7
, Issue.2
, pp. 167-169
-
-
Supersaxo, A.1
Hein, W.R.2
Steffen, H.3
-
15
-
-
80053228071
-
Secretion of adipokines by human adipose tissue in vivo: Partitioning between capillary and lymphatic transport
-
Miller NE, et al. Secretion of adipokines by human adipose tissue in vivo: partitioning between capillary and lymphatic transport. Am J Physiol Endocrinol Metab. 2011;301(4):E659-E667.
-
(2011)
Am J Physiol Endocrinol Metab
, vol.301
, Issue.4
, pp. E659-E667
-
-
Miller, N.E.1
-
16
-
-
79960373302
-
Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
-
Smirnov D, Schmidt JJ, Capecchi JT, Wightman PD. Vaccine adjuvant activity of 3M-052: an imidazoquinoline designed for local activity without systemic cytokine induction. Vaccine. 2011;29(33):5434-5442.
-
(2011)
Vaccine
, vol.29
, Issue.33
, pp. 5434-5442
-
-
Smirnov, D.1
Schmidt, J.J.2
Capecchi, J.T.3
Wightman, P.D.4
-
17
-
-
84876561994
-
Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice
-
Kourtis IC, et al. Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One. 2013;8(4):e61646.
-
(2013)
PLoS One
, vol.8
, Issue.4
, pp. e61646
-
-
Kourtis, I.C.1
-
18
-
-
70849093813
-
Materials engineering for immunomodulation
-
Hubbell JA, Thomas SN, Swartz MA. Materials engineering for immunomodulation. Nature. 2009;462(7272):449-460.
-
(2009)
Nature
, vol.462
, Issue.7272
, pp. 449-460
-
-
Hubbell, J.A.1
Thomas, S.N.2
Swartz, M.A.3
-
19
-
-
78049288264
-
Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns
-
Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10(11):787-796.
-
(2010)
Nat Rev Immunol
, vol.10
, Issue.11
, pp. 787-796
-
-
Bachmann, M.F.1
Jennings, G.T.2
-
20
-
-
4344697146
-
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
-
Fifis T, et al. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J Immunol. 2004;173(5):3148.
-
(2004)
J Immunol
, vol.173
, Issue.5
, pp. 3148
-
-
Fifis, T.1
-
21
-
-
35148889797
-
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
-
Reddy ST, et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol. 2007;25(10):1159-1164.
-
(2007)
Nat Biotechnol
, vol.25
, Issue.10
, pp. 1159-1164
-
-
Reddy, S.T.1
-
22
-
-
33646480406
-
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
-
Reddy ST, Rehor A, Schmoekel HG, Hubbell JA, Swartz MA. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release. 2006;112(1):26-34.
-
(2006)
J Control Release
, vol.112
, Issue.1
, pp. 26-34
-
-
Reddy, S.T.1
Rehor, A.2
Schmoekel, H.G.3
Hubbell, J.A.4
Swartz, M.A.5
-
23
-
-
47049100427
-
Nanoparticles target distinct dendritic cell populations accorDing to their size
-
Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations accorDing to their size. Eur J Immunol. 2008;38(5):1404-1413.
-
(2008)
Eur J Immunol
, vol.38
, Issue.5
, pp. 1404-1413
-
-
Manolova, V.1
Flace, A.2
Bauer, M.3
Schwarz, K.4
Saudan, P.5
Bachmann, M.F.6
-
24
-
-
33644529130
-
Capturing complex 3D tissue physiology in vitro
-
Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006;7(3):211-224.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, Issue.3
, pp. 211-224
-
-
Griffith, L.G.1
Swartz, M.A.2
-
25
-
-
0030982397
-
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection
-
Oussoren C, Zuidema J, Crommelin D, Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. Biochim Biophys Acta. 1997;1328(2):261-272.
-
(1997)
Biochim Biophys Acta
, vol.1328
, Issue.2
, pp. 261-272
-
-
Oussoren, C.1
Zuidema, J.2
Crommelin, D.3
Storm, G.4
-
26
-
-
84879882264
-
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
-
Kanekiyo M, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499(7456):102-106.
-
(2013)
Nature
, vol.499
, Issue.7456
, pp. 102-106
-
-
Kanekiyo, M.1
-
27
-
-
84860335491
-
Innate immunity mediates follicular transport of particulate but not soluble protein antigen
-
Link A, Zabel F, Schnetzler Y, Titz A, Brombacher F, Bachmann MF. Innate immunity mediates follicular transport of particulate but not soluble protein antigen. J Immunol. 2012;188(8):3724-3733.
-
(2012)
J Immunol
, vol.188
, Issue.8
, pp. 3724-3733
-
-
Link, A.1
Zabel, F.2
Schnetzler, Y.3
Titz, A.4
Brombacher, F.5
Bachmann, M.F.6
-
28
-
-
0034898470
-
Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies
-
Chackerian B, Lowy DR, Schiller JT. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J Clin Invest. 2001;108(3):415.
-
(2001)
J Clin Invest
, vol.108
, Issue.3
, pp. 415
-
-
Chackerian, B.1
Lowy, D.R.2
Schiller, J.T.3
-
29
-
-
79951899834
-
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
-
Moon JJ, et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater. 2011;10(3):243-251.
-
(2011)
Nat Mater
, vol.10
, Issue.3
, pp. 243-251
-
-
Moon, J.J.1
-
30
-
-
81055130325
-
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
-
Nembrini C, et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A. 2011;108(44):E989-E997.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.44
, pp. E989-E997
-
-
Nembrini, C.1
-
31
-
-
84884676871
-
Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination
-
Li AV, et al. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci Transl Med. 2013;5(204):204ra130.
-
(2013)
Sci Transl Med
, vol.5
, Issue.204
, pp. 204ra130
-
-
Li, A.V.1
-
32
-
-
78049361384
-
TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis
-
Demento SL, et al. TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J Immunol. 2010;185(5):2989-2997.
-
(2010)
J Immunol
, vol.185
, Issue.5
, pp. 2989-2997
-
-
Demento, S.L.1
-
33
-
-
77953961068
-
Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response
-
Henriksen-Lacey M, et al. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release. 2010;145(2):102-108.
-
(2010)
J Control Release
, vol.145
, Issue.2
, pp. 102-108
-
-
Henriksen-Lacey, M.1
-
34
-
-
84915751154
-
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human
-
van Dissel JT, et al. A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine. 2014;32(52):7098-7107.
-
(2014)
Vaccine
, vol.32
, Issue.52
, pp. 7098-7107
-
-
Van Dissel, J.T.1
-
35
-
-
84856387516
-
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
-
Moon JJ, Suh H, Li AV, Ockenhouse CF, Yadava A, Irvine DJ. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc Natl Acad Sci U S A. 2012;109(4):1080-1085.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, Issue.4
, pp. 1080-1085
-
-
Moon, J.J.1
Suh, H.2
Li, A.V.3
Ockenhouse, C.F.4
Yadava, A.5
Irvine, D.J.6
-
36
-
-
84897954314
-
Structure-based programming of lymph-node targeting in molecular vaccines
-
Liu H, et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature. 2014;507(7493):519-522.
-
(2014)
Nature
, vol.507
, Issue.7493
, pp. 519-522
-
-
Liu, H.1
-
37
-
-
84900461408
-
Development and function of dendritic cell subsets
-
Mildner A, Jung S. Development and function of dendritic cell subsets. Immunity. 2014;40(5):642-656.
-
(2014)
Immunity
, vol.40
, Issue.5
, pp. 642-656
-
-
Mildner, A.1
Jung, S.2
-
38
-
-
33846636409
-
Differential antigen processing by dendritic cell subsets in vivo
-
Dudziak D, et al. Differential antigen processing by dendritic cell subsets in vivo. Science. 2007;315(5808):107-111.
-
(2007)
Science
, vol.315
, Issue.5808
, pp. 107-111
-
-
Dudziak, D.1
-
39
-
-
84255186425
-
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
-
Tacken PJ, et al. Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood. 2011;118(26):6836-6844.
-
(2011)
Blood
, vol.118
, Issue.26
, pp. 6836-6844
-
-
Tacken, P.J.1
-
40
-
-
40449116336
-
Engineered lentivector targeting of dendritic cells for in vivo immunization
-
Yang L, et al. Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol. 2008;26(3):326-334.
-
(2008)
Nat Biotechnol
, vol.26
, Issue.3
, pp. 326-334
-
-
Yang, L.1
-
41
-
-
84899073975
-
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205
-
Dhodapkar MV, et al. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci Transl Med. 2014;6(232):232ra251.
-
(2014)
Sci Transl Med
, vol.6
, Issue.232
, pp. 232ra251
-
-
Dhodapkar, M.V.1
-
42
-
-
84856557403
-
Boosting antibody responses by targeting antigens to dendritic cells
-
Caminschi I, Shortman K. Boosting antibody responses by targeting antigens to dendritic cells. Trends Immunol. 2012;33(2):71-77.
-
(2012)
Trends Immunol
, vol.33
, Issue.2
, pp. 71-77
-
-
Caminschi, I.1
Shortman, K.2
-
43
-
-
34748886192
-
Dendritic-cell immunotherapy: From ex vivo loaDing to in vivo targeting
-
Tacken PJ, de Vries IJM, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loaDing to in vivo targeting. Nat Rev Immunol. 2007;7(10):790-802.
-
(2007)
Nat Rev Immunol
, vol.7
, Issue.10
, pp. 790-802
-
-
Tacken, P.J.1
De Vries, I.J.M.2
Torensma, R.3
Figdor, C.G.4
-
44
-
-
35349028297
-
Glaxo-SmithKline Adjuvant Systems in vaccines: Concepts, achievements and perspectives
-
Garçon N, Chomez P, Van Mechelen M. Glaxo-SmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives. Expert Rev Vaccines. 2007;6(5):723-739.
-
(2007)
Expert Rev Vaccines
, vol.6
, Issue.5
, pp. 723-739
-
-
Garçon, N.1
Chomez, P.2
Van Mechelen, M.3
-
45
-
-
57649115306
-
Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age
-
Bejon P, et al. Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med. 2008;359(24):2521-2532.
-
(2008)
N Engl J Med
, vol.359
, Issue.24
, pp. 2521-2532
-
-
Bejon, P.1
-
46
-
-
78751704428
-
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: A randomised controlled trial
-
Olotu A, et al. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis. 2011;11(2):102-109.
-
(2011)
Lancet Infect Dis
, vol.11
, Issue.2
, pp. 102-109
-
-
Olotu, A.1
-
47
-
-
84899912149
-
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
-
Ilyinskii PO, et al. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine. 2014;32(24):2882-2895.
-
(2014)
Vaccine
, vol.32
, Issue.24
, pp. 2882-2895
-
-
Ilyinskii, P.O.1
-
48
-
-
79952173864
-
Programming the magnitude and persistence of antibody responses with innate immunity
-
Kasturi SP, et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature. 2011;470(7335):543-547.
-
(2011)
Nature
, vol.470
, Issue.7335
, pp. 543-547
-
-
Kasturi, S.P.1
-
49
-
-
84930388443
-
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants
-
Hanson MC, et al. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. J Clin Invest. 2015;125(6):2352-2546.
-
(2015)
J Clin Invest
, vol.125
, Issue.6
, pp. 2352-2546
-
-
Hanson, M.C.1
-
50
-
-
84911911677
-
Rational design of small molecules as vaccine adjuvants
-
Wu TY-H, et al. Rational design of small molecules as vaccine adjuvants. Sci Transl Med. 2014;6(263):263ra160.
-
(2014)
Sci Transl Med
, vol.6
, Issue.263
, pp. 263ra160
-
-
Wu, T.Y.-H.1
-
51
-
-
77953541634
-
Inflammatory cytokines as a third signal for T cell activation
-
Curtsinger JM, Mescher MF. Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol. 2010;22(3):333-340.
-
(2010)
Curr Opin Immunol
, vol.22
, Issue.3
, pp. 333-340
-
-
Curtsinger, J.M.1
Mescher, M.F.2
-
52
-
-
79956079190
-
Immunological mechanisms of vaccination
-
Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol. 2011;12(6):509-517.
-
(2011)
Nat Immunol
, vol.12
, Issue.6
, pp. 509-517
-
-
Pulendran, B.1
Ahmed, R.2
-
53
-
-
84907302142
-
Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction
-
Desch AN, et al. Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction. Nat Commun. 2014;5:4674.
-
(2014)
Nat Commun
, vol.5
, pp. 4674
-
-
Desch, A.N.1
-
54
-
-
13944260898
-
Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function
-
Sporri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol. 2005;6(2):163-170.
-
(2005)
Nat Immunol
, vol.6
, Issue.2
, pp. 163-170
-
-
Sporri, R.1
Reis Sousa, E.C.2
-
55
-
-
27844541797
-
Control of B-cell responses by Toll-like receptors
-
Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature. 2005;438(7066):364-368.
-
(2005)
Nature
, vol.438
, Issue.7066
, pp. 364-368
-
-
Pasare, C.1
Medzhitov, R.2
-
56
-
-
33645734929
-
Toll-dependent selection of microbial antigens for presentation by dendritic cells
-
Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature. 2006;440(7085):808-812.
-
(2006)
Nature
, vol.440
, Issue.7085
, pp. 808-812
-
-
Blander, J.M.1
Medzhitov, R.2
-
57
-
-
70350569886
-
Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines
-
Steers NJ, Peachman KK, McClain S, Alving CR, Rao M. Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines. Vaccine. 2009;27(49):6939-6949.
-
(2009)
Vaccine
, vol.27
, Issue.49
, pp. 6939-6949
-
-
Steers, N.J.1
Peachman, K.K.2
McClain, S.3
Alving, C.R.4
Rao, M.5
-
58
-
-
78650546875
-
PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration
-
Stano A, van der Vlies AJ, Martino MM, Swartz MA, Hubbell JA, Simeoni E. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine. 2011;29(4):804-812.
-
(2011)
Vaccine
, vol.29
, Issue.4
, pp. 804-812
-
-
Stano, A.1
Van Der Vlies, A.J.2
Martino, M.M.3
Swartz, M.A.4
Hubbell, J.A.5
Simeoni, E.6
-
59
-
-
79952745936
-
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response
-
Hou B, et al. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity. 2011;34(3):375-384.
-
(2011)
Immunity
, vol.34
, Issue.3
, pp. 375-384
-
-
Hou, B.1
-
60
-
-
84868094428
-
Nano-particle vaccination combined with TLR-7 and-9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients
-
Goldinger SM, et al. Nano-particle vaccination combined with TLR-7 and-9 ligands triggers memory and effector CD8(+) T-cell responses in melanoma patients. Eur J Immunol. 2012;42(11):3049-3061.
-
(2012)
Eur J Immunol
, vol.42
, Issue.11
, pp. 3049-3061
-
-
Goldinger, S.M.1
-
61
-
-
34247891509
-
Immunologically active autoantigens: The role of toll-like receptors in the development of chronic inflammatory disease
-
Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol. 2007;25:419-441.
-
(2007)
Annu Rev Immunol
, vol.25
, pp. 419-441
-
-
Marshak-Rothstein, A.1
Rifkin, I.R.2
-
62
-
-
84920935888
-
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
-
Maldonado RA, et al. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc Natl Acad Sci U S A. 2015;112(2):E156-E165.
-
(2015)
Proc Natl Acad Sci U S A
, vol.112
, Issue.2
, pp. E156-E165
-
-
Maldonado, R.A.1
-
63
-
-
42949160629
-
The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles
-
Malyala P, et al. The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci. 2008;97(3):1155-1164.
-
(2008)
J Pharm Sci
, vol.97
, Issue.3
, pp. 1155-1164
-
-
Malyala, P.1
-
64
-
-
80053161466
-
In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles
-
Jewell CM, Lopez SC, Irvine DJ. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc Natl Acad Sci U S A. 2011;108(38):15745-15750.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.38
, pp. 15745-15750
-
-
Jewell, C.M.1
Lopez, S.C.2
Irvine, D.J.3
-
65
-
-
27244443079
-
HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates
-
Wille-Reece U, et al. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci U S A. 2005;102(42):15190-15194.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, Issue.42
, pp. 15190-15194
-
-
Wille-Reece, U.1
-
66
-
-
79955505656
-
Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type i IFN, and multiple DC subsets
-
Kastenmüller K, et al. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest. 2011;121(5):1782.
-
(2011)
J Clin Invest
, vol.121
, Issue.5
, pp. 1782
-
-
Kastenmüller, K.1
-
67
-
-
80052941503
-
TLR7 enables cross-presentation by multiple dendritic cell subsets through a type i IFN-dependent pathway
-
Oh JZ, Kurche JS, Burchill MA, Kedl RM. TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway. Blood. 2011;118(11):3028-3038.
-
(2011)
Blood
, vol.118
, Issue.11
, pp. 3028-3038
-
-
Oh, J.Z.1
Kurche, J.S.2
Burchill, M.A.3
Kedl, R.M.4
-
68
-
-
84946572121
-
In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
-
Lynn GM, et al. In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity. Nat Biotechnol. 2015;33(11):1201-1210.
-
(2015)
Nat Biotechnol
, vol.33
, Issue.11
, pp. 1201-1210
-
-
Lynn, G.M.1
-
69
-
-
84889650175
-
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
-
de Titta A, et al. Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A. 2013;110(49):19902-19907.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, Issue.49
, pp. 19902-19907
-
-
De Titta, A.1
-
70
-
-
79951899834
-
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
-
Moon JJ, et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater. 2011;10(3):243-251.
-
(2011)
Nat Mater
, vol.10
, Issue.3
, pp. 243-251
-
-
Moon, J.J.1
-
71
-
-
23944489407
-
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
-
Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005;6(8):769-776.
-
(2005)
Nat Immunol
, vol.6
, Issue.8
, pp. 769-776
-
-
Napolitani, G.1
Rinaldi, A.2
Bertoni, F.3
Sallusto, F.4
Lanzavecchia, A.5
-
72
-
-
84856988610
-
Simultaneous targeting of toll-and nod-like receptors induces effective tumorspecific immune responses
-
Garaude J, Kent A, van Rooijen N, Blander JM. Simultaneous targeting of toll-and nod-like receptors induces effective tumorspecific immune responses. Sci Transl Med. 2012;4(120):120ra116.
-
(2012)
Sci Transl Med
, vol.4
, Issue.120
, pp. 120ra116
-
-
Garaude, J.1
Kent, A.2
Van Rooijen, N.3
Blander, J.M.4
-
73
-
-
84894593765
-
Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques
-
Moody MA, et al. Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. J Virol. 2014;88(6):3329-3339.
-
(2014)
J Virol
, vol.88
, Issue.6
, pp. 3329-3339
-
-
Moody, M.A.1
-
74
-
-
84878039584
-
A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening
-
Garcia-Cordero JL, Nembrini C, Stano A, Hubbell JA, Maerkl SJ. A high-throughput nanoimmunoassay chip applied to large-scale vaccine adjuvant screening. Integr Biol (Camb). 2013;5(4):650-658.
-
(2013)
Integr Biol (Camb)
, vol.5
, Issue.4
, pp. 650-658
-
-
Garcia-Cordero, J.L.1
Nembrini, C.2
Stano, A.3
Hubbell, J.A.4
Maerkl, S.J.5
-
75
-
-
84856918906
-
Toll-like receptor (TLR)-7 and-8 modulatory activities of dimeric imidazoquinolines
-
Shukla NM, Mutz CA, Malladi SS, Warshakoon HJ, Balakrishna R, David SA. Toll-like receptor (TLR)-7 and-8 modulatory activities of dimeric imidazoquinolines. J Med Chem. 2012;55(3):1106-1116.
-
(2012)
J Med Chem
, vol.55
, Issue.3
, pp. 1106-1116
-
-
Shukla, N.M.1
Mutz, C.A.2
Malladi, S.S.3
Warshakoon, H.J.4
Balakrishna, R.5
David, S.A.6
-
77
-
-
84896747213
-
A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93
-
Orr MT, et al. A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93. PLoS One. 2014;9(1):e83884.
-
(2014)
PLoS One
, vol.9
, Issue.1
, pp. e83884
-
-
Orr, M.T.1
-
78
-
-
79952107221
-
Contributions of humoral and cellular immunity to vaccine-induced protection in humans
-
Amanna IJ, Slifka MK. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology. 2011;411(2):206-215.
-
(2011)
Virology
, vol.411
, Issue.2
, pp. 206-215
-
-
Amanna, I.J.1
Slifka, M.K.2
-
79
-
-
84875538701
-
The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling
-
Mattila PK, et al. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity. 2013;38(3):461-474.
-
(2013)
Immunity
, vol.38
, Issue.3
, pp. 461-474
-
-
Mattila, P.K.1
-
80
-
-
0042689324
-
Molecular determinants of immunogenicity: The immunon model of immune response
-
Dintzis H, Dintzis R, Vogelstein B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci U S A. 1976;73(10):3671-3675.
-
(1976)
Proc Natl Acad Sci U S A
, vol.73
, Issue.10
, pp. 3671-3675
-
-
Dintzis, H.1
Dintzis, R.2
Vogelstein, B.3
-
81
-
-
34248549520
-
Activating B cell signaling with defined multivalent ligands
-
Puffer EB, Pontrello JK, Hollenbeck JJ, Kink JA, Kiessling LL. Activating B cell signaling with defined multivalent ligands. ACS Chem Biol. 2007;2(4):252-262.
-
(2007)
ACS Chem Biol
, vol.2
, Issue.4
, pp. 252-262
-
-
Puffer, E.B.1
Pontrello, J.K.2
Hollenbeck, J.J.3
Kink, J.A.4
Kiessling, L.L.5
-
82
-
-
84901744022
-
Delivery of polysaccharides using polymer particles: Implications on size-dependent immunogenicity, opsonophagocytosis, and protective immunity
-
Anish C, Khan N, Upadhyay AK, Sehgal D, Panda AK. Delivery of polysaccharides using polymer particles: implications on size-dependent immunogenicity, opsonophagocytosis, and protective immunity. Mol Pharm. 2014;11(3):922-937.
-
(2014)
Mol Pharm
, vol.11
, Issue.3
, pp. 922-937
-
-
Anish, C.1
Khan, N.2
Upadhyay, A.K.3
Sehgal, D.4
Panda, A.K.5
-
83
-
-
33644777602
-
Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation
-
Kim Y-M, Pan JY-J, Korbel GA, Peperzak V, Boes M, Ploegh HL. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation. Proc Natl Acad Sci U S A. 2006;103(9):3327-3332.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, Issue.9
, pp. 3327-3332
-
-
Kim, Y.-M.1
Pan, J.Y.-J.2
Korbel, G.A.3
Peperzak, V.4
Boes, M.5
Ploegh, H.L.6
-
84
-
-
0036856574
-
Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation
-
Jegerlehner A, Storni T, Lipowsky G, Schmid M, Pumpens P, Bachmann MF. Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur J Immunol. 2002;32(11):3305-3314.
-
(2002)
Eur J Immunol
, vol.32
, Issue.11
, pp. 3305-3314
-
-
Jegerlehner, A.1
Storni, T.2
Lipowsky, G.3
Schmid, M.4
Pumpens, P.5
Bachmann, M.F.6
-
85
-
-
84900009827
-
Targeting and activation of antigenspecific B-cells by calcium phosphate nanoparticles loaded with protein antigen
-
Temchura VV, Kozlova D, Sokolova V, Uberla K, Epple M. Targeting and activation of antigenspecific B-cells by calcium phosphate nanoparticles loaded with protein antigen. Biomaterials. 2014;35(23):6098-6105.
-
(2014)
Biomaterials
, vol.35
, Issue.23
, pp. 6098-6105
-
-
Temchura, V.V.1
Kozlova, D.2
Sokolova, V.3
Uberla, K.4
Epple, M.5
-
86
-
-
0027764291
-
The influence of antigen organization on B cell responsiveness
-
Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM. The influence of antigen organization on B cell responsiveness. Science. 1993;262(5138):1448-1451.
-
(1993)
Science
, vol.262
, Issue.5138
, pp. 1448-1451
-
-
Bachmann, M.F.1
Rohrer, U.H.2
Kundig, T.M.3
Burki, K.4
Hengartner, H.5
Zinkernagel, R.M.6
-
87
-
-
44449151190
-
Viruslike display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model
-
Chackerian B, Durfee MR, Schiller JT. Viruslike display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model. J Immunol. 2008;180(9):5816-5825.
-
(2008)
J Immunol
, vol.180
, Issue.9
, pp. 5816-5825
-
-
Chackerian, B.1
Durfee, M.R.2
Schiller, J.T.3
-
88
-
-
84886185369
-
Virus-like particle vaccines: Advantages and challenges
-
In: Singh M, Srivastava IK, eds.. Hoboken, New Jersey, USA: John Wiley & Sons, Inc
-
Ross TM, et al. Virus-like particle vaccines: advantages and challenges. In: Singh M, Srivastava IK, eds. Development of Vaccines: From Discovery to Clinical Testing. Hoboken, New Jersey, USA: John Wiley & Sons, Inc; 2011:95-124.
-
(2011)
Development of Vaccines: From Discovery to Clinical Testing
, pp. 95-124
-
-
Ross, T.M.1
-
89
-
-
76249096897
-
A self-assembling peptide acting as an immune adjuvant
-
Rudra JS, Tian YF, Jung JP, Collier JH. A self-assembling peptide acting as an immune adjuvant. Proc Natl Acad Sci U S A. 2010;107(2):622-627.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.2
, pp. 622-627
-
-
Rudra, J.S.1
Tian, Y.F.2
Jung, J.P.3
Collier, J.H.4
-
90
-
-
84881580700
-
A self-adjuvanting supramolecular vaccine carrying a folded protein antigen
-
Hudalla GA, et al. A self-adjuvanting supramolecular vaccine carrying a folded protein antigen. Adv Healthc Mater. 2013;2(8):1114-1119.
-
(2013)
Adv Healthc Mater
, vol.2
, Issue.8
, pp. 1114-1119
-
-
Hudalla, G.A.1
-
91
-
-
84863568613
-
Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope
-
Rudra JS, et al. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. Biomaterials. 2012;33(27):6476-6484.
-
(2012)
Biomaterials
, vol.33
, Issue.27
, pp. 6476-6484
-
-
Rudra, J.S.1
-
92
-
-
77955840812
-
Synthetic virus-like particles from self-assembling coiledcoil lipopeptides and their use in antigen display to the immune system
-
Boato F, Thomas RM, Ghasparian A, Freund-Renard A, Moehle K, Robinson JA. Synthetic virus-like particles from self-assembling coiledcoil lipopeptides and their use in antigen display to the immune system. Angew Chem Int Ed Engl. 2007;119(47):9173-9176.
-
(2007)
Angew Chem Int Ed Engl
, vol.119
, Issue.47
, pp. 9173-9176
-
-
Boato, F.1
Thomas, R.M.2
Ghasparian, A.3
Freund-Renard, A.4
Moehle, K.5
Robinson, J.A.6
-
93
-
-
84934954773
-
HIV-1 vaccines
-
Jardine JG, et al. HIV-1 vaccines. Science. 2015;349(6244):156-161.
-
(2015)
Science
, vol.349
, Issue.6244
, pp. 156-161
-
-
Jardine, J.G.1
-
94
-
-
84882413295
-
Multiple antigenpresenting system (MAPS) to induce comprehensive B-and T-cell immunity
-
Zhang F, Lu YJ, Malley R. Multiple antigenpresenting system (MAPS) to induce comprehensive B-and T-cell immunity. Proc Natl Acad Sci U S A. 2013;110(33):13564-13569.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, Issue.33
, pp. 13564-13569
-
-
Zhang, F.1
Lu, Y.J.2
Malley, R.3
-
95
-
-
34447623566
-
B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node
-
Carrasco YR, Batista FD. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity. 2007;27(1):160-171.
-
(2007)
Immunity
, vol.27
, Issue.1
, pp. 160-171
-
-
Carrasco, Y.R.1
Batista, F.D.2
-
96
-
-
35948935059
-
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells
-
Junt T, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007;450(7166):110-114.
-
(2007)
Nature
, vol.450
, Issue.7166
, pp. 110-114
-
-
Junt, T.1
-
97
-
-
34548044827
-
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells
-
Phan TG, Grigorova I, Okada T, Cyster JG. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol. 2007;8(9):992-1000.
-
(2007)
Nat Immunol
, vol.8
, Issue.9
, pp. 992-1000
-
-
Phan, T.G.1
Grigorova, I.2
Okada, T.3
Cyster, J.G.4
-
98
-
-
84905111574
-
Trans-nodal migration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine
-
Woodruff MC, et al. Trans-nodal migration of resident dendritic cells into medullary interfollicular regions initiates immunity to influenza vaccine. J Exp Med. 2014;211(8):1611-1621.
-
(2014)
J Exp Med
, vol.211
, Issue.8
, pp. 1611-1621
-
-
Woodruff, M.C.1
-
99
-
-
34247149876
-
The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles
-
Pape KA, Catron DM, Itano AA, Jenkins MK. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity. 2007;26(4):491-502.
-
(2007)
Immunity
, vol.26
, Issue.4
, pp. 491-502
-
-
Pape, K.A.1
Catron, D.M.2
Itano, A.A.3
Jenkins, M.K.4
-
100
-
-
60149086845
-
Conduits mediate transport of low-molecular-weight antigen to lymph node follicles
-
Roozendaal R, et al. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity. 2009;30(2):264-276.
-
(2009)
Immunity
, vol.30
, Issue.2
, pp. 264-276
-
-
Roozendaal, R.1
-
101
-
-
21144444056
-
Dynamics and function of langerhans cells in vivo: Dermal dendritic cells colonize lymph node areasdistinct from slower migrating langerhans cells
-
Kissenpfennig A, et al. Dynamics and function of langerhans cells in vivo: dermal dendritic cells colonize lymph node areasdistinct from slower migrating langerhans cells. Immunity. 2005;22(5):643-654.
-
(2005)
Immunity
, vol.22
, Issue.5
, pp. 643-654
-
-
Kissenpfennig, A.1
-
102
-
-
35349014587
-
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
-
Wherry EJ, et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27(4):670-684.
-
(2007)
Immunity
, vol.27
, Issue.4
, pp. 670-684
-
-
Wherry, E.J.1
-
103
-
-
84866275978
-
Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics
-
Lin WH, Kouyos RD, Adams RJ, Grenfell BT, Griffin DE. Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A. 2012;109(37):14989-14994.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, Issue.37
, pp. 14989-14994
-
-
Lin, W.H.1
Kouyos, R.D.2
Adams, R.J.3
Grenfell, B.T.4
Griffin, D.E.5
-
104
-
-
77953499055
-
Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection
-
Kim TS, Hufford MM, Sun J, Fu YX, Braciale TJ. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J Exp Med. 2010;207(6):1161-1172.
-
(2010)
J Exp Med
, vol.207
, Issue.6
, pp. 1161-1172
-
-
Kim, T.S.1
Hufford, M.M.2
Sun, J.3
Fu, Y.X.4
Braciale, T.J.5
-
105
-
-
33846830004
-
Persistent antigen presentation after acute vesicular stomatitis virus infection
-
Turner DL, Cauley LS, Khanna KM, Lefrancois L. Persistent antigen presentation after acute vesicular stomatitis virus infection. J Virol. 2007;81(4):2039-2046.
-
(2007)
J Virol
, vol.81
, Issue.4
, pp. 2039-2046
-
-
Turner, D.L.1
Cauley, L.S.2
Khanna, K.M.3
Lefrancois, L.4
-
106
-
-
84875549975
-
Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype
-
Baumjohann D, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2013;38(3):596-605.
-
(2013)
Immunity
, vol.38
, Issue.3
, pp. 596-605
-
-
Baumjohann, D.1
-
107
-
-
84940995726
-
Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo
-
Benson RA, MacLeod MK, Hale BG, Patakas A, Garside P, Brewer JM. Antigen presentation kinetics control T cell/dendritic cell interactions and follicular helper T cell generation in vivo. Elife. 2015;4:e06994.
-
(2015)
Elife
, vol.4
, pp. e06994
-
-
Benson, R.A.1
MacLeod, M.K.2
Hale, B.G.3
Patakas, A.4
Garside, P.5
Brewer, J.M.6
-
108
-
-
42449141017
-
Antigen kinetics determines immune reactivity
-
Johansen P, et al. Antigen kinetics determines immune reactivity. Proc Natl Acad Sci U S A. 2008;105(13):5189-5194.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, Issue.13
, pp. 5189-5194
-
-
Johansen, P.1
-
109
-
-
34548027000
-
Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor
-
Joshi NS, et al. Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27(2):281-295.
-
(2007)
Immunity
, vol.27
, Issue.2
, pp. 281-295
-
-
Joshi, N.S.1
-
110
-
-
0034210006
-
Localization dose and time of antigens determine immune reactivity
-
Zinkernagel RM. Localization dose and time of antigens determine immune reactivity. Semin Immunol. 2000;12(3):163-171.
-
(2000)
Semin Immunol
, vol.12
, Issue.3
, pp. 163-171
-
-
Zinkernagel, R.M.1
-
111
-
-
80052665758
-
Duration of antigen availability influences the expansion and memory differentiation of T cells
-
Blair DA, et al. Duration of antigen availability influences the expansion and memory differentiation of T cells. J Immunol. 2011;187(5):2310-2321.
-
(2011)
J Immunol
, vol.187
, Issue.5
, pp. 2310-2321
-
-
Blair, D.A.1
-
112
-
-
33645856486
-
Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation
-
Paus D, Phan TG, Chan TD, Gardam S, Basten A, Brink R. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med. 2006;203(4):1081-1091.
-
(2006)
J Exp Med
, vol.203
, Issue.4
, pp. 1081-1091
-
-
Paus, D.1
Phan, T.G.2
Chan, T.D.3
Gardam, S.4
Basten, A.5
Brink, R.6
-
113
-
-
84924067611
-
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
-
Quinn KM, et al. Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. J Clin Invest. 2015;125(3):1129-1146.
-
(2015)
J Clin Invest
, vol.125
, Issue.3
, pp. 1129-1146
-
-
Quinn, K.M.1
-
114
-
-
40449088958
-
CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu
-
Shaulov A, Murali-Krishna K. CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu. J Immunol. 2008;180(2):1131-1138.
-
(2008)
J Immunol
, vol.180
, Issue.2
, pp. 1131-1138
-
-
Shaulov, A.1
Murali-Krishna, K.2
-
115
-
-
0030460025
-
In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid
-
Gupta RK, Chang AC, Griffin P, Rivera R, Siber GR. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid. Vaccine. 1996;14(15):1412-1416.
-
(1996)
Vaccine
, vol.14
, Issue.15
, pp. 1412-1416
-
-
Gupta, R.K.1
Chang, A.C.2
Griffin, P.3
Rivera, R.4
Siber, G.R.5
-
116
-
-
84862652390
-
Alum adjuvant: Some of the tricks of the oldest adjuvant
-
Kool M, Fierens K, Lambrecht BN. Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol. 2012;61(pt 7):927-934.
-
(2012)
J Med Microbiol
, vol.61
, pp. 927-934
-
-
Kool, M.1
Fierens, K.2
Lambrecht, B.N.3
-
117
-
-
84857777511
-
Antigen depot is not required for alum adjuvanticity
-
Hutchison S, Benson RA, Gibson VB, Pollock AH, Garside P, Brewer JM. Antigen depot is not required for alum adjuvanticity. FASEB J. 2012;26(3):1272-1279.
-
(2012)
FASEB J
, vol.26
, Issue.3
, pp. 1272-1279
-
-
Hutchison, S.1
Benson, R.A.2
Gibson, V.B.3
Pollock, A.H.4
Garside, P.5
Brewer, J.M.6
-
118
-
-
77950596439
-
Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response
-
Noe SM, Green MA, HogenEsch H, Hem SL. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. Vaccine. 2010;28(20):3588-3594.
-
(2010)
Vaccine
, vol.28
, Issue.20
, pp. 3588-3594
-
-
Noe, S.M.1
Green, M.A.2
HogenEsch, H.3
Hem, S.L.4
-
119
-
-
0018746463
-
A single-step immunization by sustained antigen release
-
Preis I, Langer RS. A single-step immunization by sustained antigen release. J Immunol Methods. 1979;28(1-2):193-197.
-
(1979)
J Immunol Methods
, vol.28
, Issue.1-2
, pp. 193-197
-
-
Preis, I.1
Langer, R.S.2
-
120
-
-
35349027729
-
Nanoparticles and microparticles as vaccine-delivery systems
-
Singh M, Chakrapani A, O'Hagan D. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines. 2007;6(5):797-808.
-
(2007)
Expert Rev Vaccines
, vol.6
, Issue.5
, pp. 797-808
-
-
Singh, M.1
Chakrapani, A.2
O'Hagan, D.3
-
121
-
-
81355141475
-
The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the nextgeneration vaccine adjuvant
-
Jain S, O'Hagan DT, Singh M. The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the nextgeneration vaccine adjuvant. Expert Rev Vaccines. 2011;10(12):1731-1742.
-
(2011)
Expert Rev Vaccines
, vol.10
, Issue.12
, pp. 1731-1742
-
-
Jain, S.1
O'Hagan, D.T.2
Singh, M.3
-
123
-
-
84883867736
-
Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device
-
Hirobe S, et al. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device. Pharm Res. 2013;30(10):2664-2674.
-
(2013)
Pharm Res
, vol.30
, Issue.10
, pp. 2664-2674
-
-
Hirobe, S.1
-
124
-
-
77955417028
-
Dissolving polymer microneedle patches for influenza vaccination
-
Sullivan SP, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010;16(8):915-920.
-
(2010)
Nat Med
, vol.16
, Issue.8
, pp. 915-920
-
-
Sullivan, S.P.1
-
125
-
-
84856090257
-
Fabrication of silk microneedles for controlled-release drug delivery
-
Tsioris K, Raja WK, Pritchard EM, Panilaitis B, Kaplan DL, Omenetto FG. Fabrication of silk microneedles for controlled-release drug delivery. Adv Funct Mater. 2012;22(2):330-335.
-
(2012)
Adv Funct Mater
, vol.22
, Issue.2
, pp. 330-335
-
-
Tsioris, K.1
Raja, W.K.2
Pritchard, E.M.3
Panilaitis, B.4
Kaplan, D.L.5
Omenetto, F.G.6
-
126
-
-
84872082784
-
Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination
-
Demuth PC, Garcia-Beltran WF, Ai-Ling ML, Hammond PT, Irvine DJ. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination. Adv Funct Mater. 2013;23(2):161-172.
-
(2013)
Adv Funct Mater
, vol.23
, Issue.2
, pp. 161-172
-
-
Demuth, P.C.1
Garcia-Beltran, W.F.2
Ai-Ling, M.L.3
Hammond, P.T.4
Irvine, D.J.5
-
127
-
-
84925378659
-
Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells
-
Zaric M, et al. Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells. J Invest Dermatol. 2015;135(2):425-434.
-
(2015)
J Invest Dermatol
, vol.135
, Issue.2
, pp. 425-434
-
-
Zaric, M.1
-
128
-
-
84891782974
-
Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization
-
DeMuth PC, Min Y, Irvine DJ, Hammond PT. Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization. Adv Healthc Mater. 2014;3(1):47-58.
-
(2014)
Adv Healthc Mater
, vol.3
, Issue.1
, pp. 47-58
-
-
DeMuth, P.C.1
Min, Y.2
Irvine, D.J.3
Hammond, P.T.4
-
129
-
-
84875412118
-
Polymer multilayer tattooing for enhanced DNA vaccination
-
DeMuth PC, et al. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater. 2013;12(4):367-376.
-
(2013)
Nat Mater
, vol.12
, Issue.4
, pp. 367-376
-
-
DeMuth, P.C.1
-
130
-
-
84864364745
-
Stabilization of vaccines and antibiotics in silk and eliminating the cold chain
-
Zhang J, et al. Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proc Natl Acad Sci U S A. 2012;109(30):11981-11986.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, Issue.30
, pp. 11981-11986
-
-
Zhang, J.1
-
131
-
-
58949100114
-
Infection-mimicking materials to program dendritic cells in situ
-
Ali OA, Huebsch N, Cao L, Dranoff G, Mooney DJ. Infection-mimicking materials to program dendritic cells in situ. Nat Mater. 2009;8(2):151-158.
-
(2009)
Nat Mater
, vol.8
, Issue.2
, pp. 151-158
-
-
Ali, O.A.1
Huebsch, N.2
Cao, L.3
Dranoff, G.4
Mooney, D.J.5
-
132
-
-
84896523011
-
Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants
-
Ali OA, et al. Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants. Cancer Res. 2014;74(6):1670-1681.
-
(2014)
Cancer Res
, vol.74
, Issue.6
, pp. 1670-1681
-
-
Ali, O.A.1
-
133
-
-
77953720628
-
In situ regulation of DC subsets and T cells mediates tumor regression in mice
-
Ali OA, Emerich D, Dranoff G, Mooney DJ. In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci Transl Med. 2009;1(8):8ra19.
-
(2009)
Sci Transl Med
, vol.1
, Issue.8
, pp. 8ra19
-
-
Ali, O.A.1
Emerich, D.2
Dranoff, G.3
Mooney, D.J.4
|